@airportroster · Post #904 · 06/12/2022, 09:58 AM
#编号688#墓碑 #GMPORA#GMP 收录时间: 2022.06.12 官网: gmpora.me 群组: @pay_yueluoyun_xyz_Tg 频道: @GMPORAV 商店截图 已被转手。 📖-------> 目录 <------- 📖
TGINSIGHT SIMILAR POSTS
Source channel @githubtrending · Post #15039 · Aug 8
#python#adk#agent_samples#agents The Agent Development Kit (ADK) offers ready-made sample agents in Python and Java to help you quickly build AI-powered agents for various tasks, from simple chatbots to complex multi-agent workflows. It supports flexible design, letting you combine multiple specialized agents, use diverse tools, and create adaptable workflows. ADK also includes developer tools for easy testing, debugging, and deployment, and works well with Google’s AI models and other large language models. Using these samples can save you time and effort by providing practical examples and a strong foundation to develop your own intelligent agents efficiently. This helps you focus on your agent’s logic while ADK handles orchestration and scaling. https://github.com/google/adk-samples
Hashtags
Search: #gmp
@airportroster · Post #904 · 06/12/2022, 09:58 AM
#编号688#墓碑 #GMPORA#GMP 收录时间: 2022.06.12 官网: gmpora.me 群组: @pay_yueluoyun_xyz_Tg 频道: @GMPORAV 商店截图 已被转手。 📖-------> 目录 <------- 📖
@OnlineEducation10 · Post #136 · 03/24/2021, 04:01 AM
#Biopharma Institute offers effective and engaging #RemoteLearning solutions in Good Manufacturing Practice and Good Clinical Practice. Earn your #GMP & #GCP professional certification. http://biopharmainstitute.com 👌 Join @OnlineEducation10
@venturevillagewall · Post #3629 · 12/21/2024, 10:22 AM
$4.07M Funding for PeptiSystems PeptiSystems secured $4.07M in funding on December 20, 2024. The company develops advanced instruments for solid-phase synthesis in peptide and oligonucleotide therapeutics, catering to both GMP and non-GMP manufacturing. Discover more: PeptiSystems #Funding#PeptiSystems#Therapeutics#Peptides#Oligonucleotides#GMP#Manufacturing#Synthesis#Biotechnology#Pharmaceuticals#MedicalDevices#FlowthroughColumnTechnology#ProcessDevelopment#LifeSciences